Carverter is a technology platform that enables customers to find and lease a hybrid or Electric Vehicle (EV). The company cites data pointing out the UK government's ban on the sale of petrol and diesel only cars after 2030. It also argues about changing car preferences, with 78% of consumers considering leasing to access an EV. Carverter aims to capture this audience and grow its business. The company uses its algorithm to bring together over 32 million data points across its three tools, namely Carvert, Carwizard, and Browse, to help users find their choice of hybrid/EV. Carverter has partnered with renowned entities like WPP, Arval, Microsoft & ITV to boost its business. It will use 10% of the investment on hiring staff, 20% towards rolling out its services across 22 European countries via Arval, and 70% on an advertising multiplier deal with the UK's largest commercial broadcaster, ITV, and WPP.
days to go:
Expired
investment:
£2,324,693
B-North is creating an SME business bank that will deliver fast decisions with loans being given in two weeks. Its model is formed around strong relationships with both brokers and customers. B-North is in a positive conversation with the British Business Bank for Tier 2 debt, and its FinTech enabled lending platform is excellent. The funds will be used to expand the team and develop the platform. The company also aims at assembling a highly-experienced and ambitious management team supported by a heavyweight board.
days to go:
Expired
investment:
£2,815,350
With new MiFID II regulations introduced in January, Hiddensee provides independent investment research mainly on forensic accounting and corporate governance. Analysts will search for inconsistencies and anomalies in the valuation of UK listed mid-cap and smaller companies and publish their reports to assist investors in deciding whether to buy or sell shares.
days to go:
Expired
investment:
£143,097
HealthBox Software is a technology company building products for the post-COVID healthcare landscape. Its first product, ClearPass, was met with success. The tool asks an employee a series of screening questions related to COVID-19, including evidence of fever, fatigue, and dry cough, etc. ClearPass has over 400,000 end-users including companies like Johnson Controls, Remy Cointreau and the San Diego School District. HealthBox aims to be a significant contender in the global digital health market that is expected to be worth $600 billion by 2026. The company is on the verge of launching another innovative product, MyHealthBox. It is a consumer-facing digital health app that will allow users to store their medical records, easily accessible 24/7. HealthBox asserts that the app will have an array of features, including AI health assessment services, dietary advice and data-powered lifestyle guidance. The company will use 47% of the investment towards technology and development costs, and 53% towards sales and marketing.
days to go:
Expired
investment:
£144,265
Customers can have the chance to win highly desirable properties ranging from £350,000 to £650,000. After purchasing a £5 ticket and answering one multiple-choice question correctly, customers will be entered into a draw to win a property. Raffle House also donate 5% of their ticket sales revenue to a homelessness charity chosen by their customers.
days to go:
Expired
investment:
£269,419
Rightangled is a healthcare technology company backed by NHS England & regulated by the Care Quality Commission (CQC). It began its journey as a platform that would enable the use of genetic information within the medical practice, in an accurate, streamlined, and affordable way. It gradually established itself as a healthcare provider for screening and diagnostic services. Its Heart DNA Test project, launched in 2017, is helping patients minimize their cardiac risks and enabling doctors to have a complete risk profile for their patients. The project was appreciated and received funding from NHS England. Its next project, Fitness DNA Test, tapped into the fitness and wellbeing markets. Recently, in the wake of the COVID-19 threat, the company has developed a home-based throat swab test to detect the viral infection, by testing viral load presented in its nucleic acid material within (RNA). For its efforts, Rightangled has been featured on CNN, Sky News, LBC radio, Sky News radio, and Newsweek. With the investment, the company aims to release a mobile application by the end of 2020, and develop an AI system to give instant tailored health, diet, and fitness advice to its users based on the data gathered from patient-doctor interactions and patient responses.
days to go:
Expired
investment:
£522,689
The Gut Stuff is a proactive advocate for gut health, educating a substantial community and offering an innovative app in BETA that aims to bridge gaps in the gut health market. With a strong presence in physical products, workplace education, and media, they're positioned to redefine the gut health category and leverage diversified revenue streams for growth during their expansion into the digital realm.
days to go:
Expired
investment:
£321,662
Avida Global (AG) is a Business-to-Business (B2B) producer of high-quality medicinal cannabis oils and derivatives for the global medical, well-being and cosmeceutical markets. The company has a cultivation and processing facility in North-East Colombia. It asserts that the therapeutic properties of the cannabis plant has driven 53 countries to legalise its use, with more to follow. AG seeks to capture this demand and become a contender in the medicinal cannabis market that is expected to soar from $33.1 billion to $84.0 billion by 2028. The company has received regulatory approvals for initial non-psychoactive cannabis cultivation, manufacturing, and export licences in 2019. It is working on a partnership with a medicinal cannabis prescriber through doctors and clinics for the supply of medicinal cannabis strains in the UK. The company will use 40% of the investment to drive revenue growth, 25% as capital expenses, and 35% as additional operating expenses.
days to go:
Expired
investment:
£1,646,249
Zvilo aims to become a major challenger bank in the Balkans for Balkan people living in the European Economic Area (EEA). It plans to disrupt the outdated Balkan banking sector and become a contender in an estimated remittances per annum market worth €14 billion. The company asserts that it has procured a letter of intent for a pilot program that would allow it to offer business lending to 800+ Small and Medium Enterprises (SMEs) and financial services to 45,000+ potential personal banking customers. It has also initiated a licensing application with the Central Bank of Kosovo and partnered with Mastercard as its card partner. Zvilo will use the investment to formalise its application for Supply Chain Finance (SCF) licensing in Kosovo, execute its strategic partnership agreement with its Kosovar partner retailer, prepare for a second fundraising round, and expand its services.
days to go:
Expired
investment:
£666,085
Over the past 8 years, Advatech Healthcare has created Hippo, a proven disabled and non-emergency patients transportation services (NEPTS) in the Essex area. Due to its dependability and efficiency, Hippo is now poised to become the UK's best national wheelchair accessible healthcare services on a wearable technology platform. According to the Office for Technology Statistics data, there are 13.37 million people disabled in the UK who lack dedicated non-emergency transportation. Hippo could save the National Health Service (NHS) up to 60% on transportation costs increasing faster hospital bed rotation and providing dedicated transportation for disabled and non-emergency patients with a medically trained staff. It also offers medical and technological necessities not offered by many leading operators. Currently, the company operates within the Essex area. By the end of 2020, the company aims to commence seven new contracts it has signed with the NHS. It also signed a deal with Cambridge Adult Social Care that is expected to close, within a 5-year term and generate over £200,000 per year.
days to go:
Expired
investment:
Withheld
